Published in Ann Rheum Dis on September 01, 1986
Evaluation of pulmonary function and quality of life in women with osteoporosis. Osteoporos Int (2005) 1.14
Relation between chest expansion, pulmonary function, and exercise tolerance in patients with ankylosing spondylitis. Ann Rheum Dis (1990) 1.11
Restrictive pulmonary function is more prevalent in patients with ankylosing spondylitis than in matched population controls and is associated with impaired spinal mobility: a comparative study. Arthritis Res Ther (2012) 1.06
Pulmonary involvement in ankylosing spondylitis. Clin Rheumatol (2006) 1.00
Lung findings on thoracic high-resolution computed tomography in patients with ankylosing spondylitis. Correlations with disease duration, clinical findings and pulmonary function testing. Clin Rheumatol (2004) 0.97
Home-based exercise therapy in patients with ankylosing spondylitis: effects on pain, mobility, disease activity, quality of life, and respiratory functions. Clin Rheumatol (2011) 0.95
Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE). Ann Rheum Dis (2011) 0.93
Pulmonary function and maximal transrespiratory pressures in ankylosing spondylitis. Ann Rheum Dis (1989) 0.92
Comparison of early and late pleuropulmonary findings of ankylosing spondylitis by high-resolution computed tomography and effects on patients' daily life. Clin Rheumatol (2004) 0.88
Spinal mobility, vertebral squaring, pulmonary function, pain, fatigue, and quality of life in patients with ankylosing spondylitis. Ann Rehabil Med (2013) 0.83
Prevalence and characteristics of lung involvement on high resolution computed tomography in patients with ankylosing spondylitis: a systematic review. Pulm Med (2012) 0.82
Pulmonary abnormalities on high-resolution computed tomography in ankylosing spondylitis: relationship to disease duration and pulmonary function testing. Rheumatol Int (2011) 0.82
Combined home exercise is more effective than range-of-motion home exercise in patients with ankylosing spondylitis: a randomized controlled trial. Biomed Res Int (2014) 0.78
Treatment of ankylosing spondylitis with biologics and targeted physical therapy: positive effect on chest pain, diminished chest mobility, and respiratory function. Z Rheumatol (2013) 0.78
Pulmonary function in ankylosing spondylitis: association with clinical variables. Rheumatol Int (2013) 0.78
Respiratory muscle strength but not BASFI score relates to diminished chest expansion in ankylosing spondylitis. Clin Rheumatol (2004) 0.77
[A comparison of respiratory muscle strength, pulmonary function tests and endurance in patients with early and late stage ankylosing spodylitis]. Z Rheumatol (2006) 0.76
Progressive Pulmonary Fibrocystic Changes of Both Upper Lungs in a Patient with Ankylosing Spondylitis. Tuberc Respir Dis (Seoul) (2015) 0.75
Bronchoalveolar lavage in ankylosing spondylitis. Ann Rheum Dis (1990) 0.75
Effects of glossopharyngeal insufflation in ankylosing spondylitis: a pilot study. Int J Rheumatol (2014) 0.75
The thorax in ankylosing spondylitis. Ann Rheum Dis (1950) 4.28
Ankylosing spondylitis and lung fibrosis. Q J Med (1972) 2.09
Reference values for lung function tests in females. Regression equations with smoking variables. Bull Eur Physiopathol Respir (1986) 1.74
Disturbed oesophageal manometric responses in patients with ankylosing spondylitis and pulmonary aspergilloma. Australas Ann Med (1970) 1.74
Quantitative analysis of the alveolar plateau in the diagnosis of early airway obstruction. Am Rev Respir Dis (1973) 1.56
Regional lung function in ankylosing spondylitis. Thorax (1976) 1.14
Ankylosing spondylitis lung disease--an underdiagnosed entity? Eur J Respir Dis (1983) 0.91
Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax (2004) 3.48
Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up. J Intern Med (2013) 2.74
Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ (1998) 2.51
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Ann Rheum Dis (2005) 2.46
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis (2005) 2.43
Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest (1983) 2.36
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J (2009) 2.21
Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis (1984) 2.02
Swedish registers to examine drug safety and clinical issues in RA. Ann Rheum Dis (2006) 1.93
Reference values for lung function tests in men: regression equations with smoking variables. Ups J Med Sci (1986) 1.77
Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med (1999) 1.76
Reference values for lung function tests in females. Regression equations with smoking variables. Bull Eur Physiopathol Respir (1986) 1.74
Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids. J Rheumatol (1996) 1.73
Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheum Dis (1994) 1.73
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register. Ann Rheum Dis (2008) 1.69
Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009. Scand J Rheumatol (2010) 1.65
Bronchial hyperresponsiveness to methacholine in patients with primary Sjögren's syndrome. Ann Rheum Dis (1991) 1.63
Enhanced local production of complement components in the small intestines of patients with Crohn's disease. N Engl J Med (1990) 1.56
Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J Clin Invest (1980) 1.56
Non-malignant asbestos pleural disease. Thorax (1981) 1.51
Nonmalignant pleural lesions due to environmental exposure to asbestos: a field-based, cross-sectional study. Eur Respir J (2005) 1.48
Environmental dangers: asbestos and tuberculosis. Respiration (2000) 1.46
Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut (2002) 1.45
Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis (1985) 1.41
Role of hyaluronan in acute pancreatitis. Surgery (2000) 1.39
Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. Metabolism (1988) 1.35
Cerebrospinal fluid ferritin in patients with cerebral infarction or bleeding. Acta Neurol Scand (1980) 1.34
Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut (1993) 1.33
The timing of glucocorticoid administration in rheumatoid arthritis. Ann Rheum Dis (1997) 1.33
Hard metal lung disease: importance of cobalt in coolants. Thorax (1980) 1.32
Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease. Br Med J (Clin Res Ed) (1985) 1.31
Enhancement of factor XII dependent reactions by eosinophil cationic protein. Thromb Res (1979) 1.30
Detection of circulating IgG aggregates and immune complexes using 125I protein A from Staphylococcus aureus. Ann Rheum Dis (1976) 1.25
Kinetic studies of phagocytosis. I. The serum independent particle uptake by PMN from patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum (1978) 1.24
Accumulation of hyaluronic acid in the alveolar interstitial tissue in bleomycin-induced alveolitis. Am Rev Respir Dis (1989) 1.24
Chylothorax and pseudochylothorax. Eur Respir J (1997) 1.24
Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. Relationship to synovitis mass and morning stiffness. Arthritis Rheum (1987) 1.23
Kinetic studies of phagocytosis of IgG-coated latex particles with a thrombocyte counter. J Lab Clin Med (1977) 1.22
Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. Thorax (1989) 1.21
Raised serum hyaluronate levels in scleroderma: an effect of growth factor induced activation of connective tissue cells? Ann Rheum Dis (1985) 1.20
Pleural plaques in a health survey material. Frequency, development and exposure to asbestos. Scand J Respir Dis (1978) 1.19
Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation. J Intern Med (1997) 1.17
Sulphasalazine in ankylosing spondylitis. Ann Rheum Dis (1986) 1.16
The pathogenesis of pleural plaques and pulmonary asbestosis: possibilities and impossibilities. Eur J Respir Dis (1980) 1.15
Ozone-induced lung function decrements do not correlate with early airway inflammatory or antioxidant responses. Eur Respir J (1999) 1.15
Radiological study of pleural changes in relation to mesothelioma in Turkey. Thorax (1983) 1.13
Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis. Ann Rheum Dis (1990) 1.12
Byssinosis in carpet weavers exposed to wool contaminated with endotoxin. Br J Ind Med (1987) 1.12
Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents. Dig Dis Sci (1998) 1.12
Studies on the phagocytic activity of the granulocytes in psoriasis and palmoplantar pustulosis. Br J Dermatol (1983) 1.11
The jejunal secretion of histamine is increased in active Crohn's disease. Gastroenterology (1990) 1.11
Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis. Arthritis Rheum (1990) 1.11
Impaired glucose handling in active rheumatoid arthritis: relationship to the secretion of insulin and counter-regulatory hormones. Metabolism (1987) 1.10
Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man. Pharm Res (1992) 1.10
Cold-induced reversible myocardial ischaemia in systemic sclerosis. Lancet (1989) 1.10
Alveolar accumulation of fibronectin and hyaluronan precedes bleomycin-induced pulmonary fibrosis in the rat. Eur Respir J (1992) 1.10
Inhalation of nitric oxide modulates adult human bronchial tone. Am Rev Respir Dis (1993) 1.09
Effects of serum and cations on the selective release of granular proteins from human netrophils during phagocytosis. Scand J Haematol (1979) 1.08
Hyaluronate and type III procollagen peptide concentrations in bronchoalveolar lavage fluid as markers of disease activity in farmer's lung. Br Med J (Clin Res Ed) (1987) 1.07
Effect of hyaluronic acid on phagocytosis of opsonized latex particles. Scand J Immunol (1980) 1.07
A new technique for segmental jejunal perfusion in man. Am J Gastroenterol (1989) 1.07
Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity. Arch Intern Med (1987) 1.07
Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment. Arch Intern Med (1987) 1.06
Hyaluronan (hyaluronic acid) in bronchoalveolar lavage fluid during the development of bleomycin-induced alveolitis in the rat. Am Rev Respir Dis (1989) 1.05
Serum osteocalcin in rheumatoid arthritis and other inflammatory arthritides: relation between inflammatory activity and the effect of glucocorticoids and remission inducing drugs. Ann Rheum Dis (1986) 1.05
Pulmonary pseudotumours and asbestos. Acta Radiol Diagn (Stockh) (1980) 1.05
Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study. Ann Rheum Dis (2006) 1.05
Is 125I iothalamate an ideal marker for glomerular filtration? Kidney Int (1985) 1.05
Extended NO analysis applied to patients with COPD, allergic asthma and allergic rhinitis. Respir Med (2002) 1.04
Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. Am J Gastroenterol (1999) 1.04
Environmental asbestos exposure and malignant pleural mesothelioma. Respir Med (1999) 1.03
Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin. Ann Rheum Dis (1992) 1.03
Serum erythropoietin in rheumatoid arthritis and other inflammatory arthritides: relationship to anaemia and the effect of anti-inflammatory treatment. Br J Haematol (1987) 1.02
Exhaled nitric oxide and its relationship to airway responsiveness and atopy in asthma. BHR-Study Group. Respir Med (1999) 1.02
Monocyte activation in rheumatoid arthritis (RA): increased integrin, Fc gamma and complement receptor expression and the effect of glucocorticoids. Clin Exp Immunol (1999) 1.01
Eosinophil cationic protein in inflammatory synovial effusions as evidence of eosinophil involvement. Ann Rheum Dis (1984) 1.01
Hyaluronan content in the kidney in different states of body hydration. Kidney Int (2000) 1.01
Investigation of the excluded stomach after Roux-en-Y gastric bypass. Obes Surg (2001) 1.00
Endotoxemia in chronic renal failure. Nephron (1987) 1.00
Magnetic resonance imaging of sacroiliac joint inflammation. Arthritis Rheum (1990) 0.99
Different airway responsiveness profiles in atopic asthma, nonatopic asthma, and Sjögren's syndrome. BHR Study Group. Bronchial hyperresponsiveness. Allergy (2000) 0.99
Malignant mesothelioma secondary to chronic inflammation and old scars. Two new cases and review of the literature. Cancer (1985) 0.99
Sleep disturbances in patients with primary Sjögren's syndrome. Br J Rheumatol (1993) 0.98
Self-reported symptoms among women after cosmetic breast implant and breast reduction surgery. Plast Reconstr Surg (2001) 0.98
Increased hyaluronan (hyaluronic acid) levels in bronchoalveolar lavage fluid after histamine inhalation. Int Arch Allergy Appl Immunol (1989) 0.98
Non-invasive assessment of left ventricular diastolic function in patients with systemic sclerosis. J Intern Med (1990) 0.97
Accumulation of hyaluronan and tissue edema in experimental myocardial infarction. J Clin Invest (1991) 0.97
Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine. Arch Intern Med (1986) 0.97
Rapid onset of action of inhaled formoterol in asthmatic patients. Chest (1992) 0.96
Anxiety and depression in patients with primary Sjögren's syndrome. J Rheumatol (2000) 0.96
A technique for segmental rectal and colonic perfusion in humans. Am J Gastroenterol (1992) 0.96
Reference values for respiratory function tests in males: prediction formulas with tobacco smoking parameters. Clin Physiol (1981) 0.95
Abdominal aortic aneurysm in homocystinuria. Acta Chir Scand (1978) 0.95
Serum ferritin during infection. A longitudinal study. Scand J Haematol (1978) 0.95